Skip to content
value.today

Celsion CORP

Total raised
$9 M
1 round on record
Latest round
$9 M
Jun 2011
First round on record
Jun 2011
Today
Went public
See the company page

Celsion CORP is listed today as Imunon, Inc.: market value, financials and filings are on its company page.

Funding rounds

1 counted as startup funding, 4 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Celsion CORP
MonthRaisedRaiseSizeInvestorsSoldFiling
May 2025$3 MPrivate placement after listing$2 to $10 million

Celsion CORP: Private sale, May 2025

Investors in this round

3 investors had bought by the notice of May 28, 2025: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $3 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them, other: Warrants and pre-funded warrants to purchase common stock and shares of common stock underlying such warrants
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$227,500
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David H. Gaiero · Executive Officer · Chief Financial Officer
  • Douglas H. Faller · Executive Officer · Chief Medical Officer
  • Khursheed H. Anwer · Executive Officer · Executive Vice President and Chief Scientific Officer
  • Michael H. Tardugno · Executive Officer, Director · Executive Chairman
  • Stacy R. Lindborg · Executive Officer, Director · President and Chief Executive Officer
  • Susan H. Eylward · Executive Officer · General Counsel and Corporate Secretary
  • Christine J. Pellizzari · Director
  • Donald P. Braun · Director
  • Frederick J. Fritz · Director
  • James E. Dentzer · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Brookline Capital Markets, a division of Arcadia Securities, LLC (CRD 000044656) · New York, New YorkSold in CA, FL, IL, NJ, NY, and outside the US
  • H.C. Wainwright & Co., LLC (CRD 000000375) · New York, New YorkSold in CA, FL, IL, NJ, NY, and outside the US

Remarks in the notice

  • On fees: “In addition to the cash fee above, the Company paid certain expenses and issued a warrant to purchase up to 361,111 shares of the Company's common stock at an exercise price of $0.5625 per share to H.C. Wainwright, LLC.”

Signed by Susan Eylward, General Counsel and Corporate Secretary. Source: SEC Form D, newest notice filed May 28, 2025. Read the notice at the SEC.

equity, optionsSEC
Aug 2024$10 MPrivate placement after listing$10 to $50 million

Celsion CORP: Private sale, Aug 2024

Investors in this round

4 investors had bought by the notice of Aug 16, 2024: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $10 M offered
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, other: Warrants to purchase common stock and shares of common stock underlying the warrants
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$700,000
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • David Gaiero · Executive Officer
  • Khursheed Anwer · Executive Officer
  • Michael Tardugno · Executive Officer
  • Stacy Lindborg · Executive Officer, Director
  • Christine Pellizzari · Director
  • Donald Braun · Director
  • Frederick Fritz · Director
  • James Dentzer · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • H.C. Wainwright & Co., LLC (CRD 000000375) · broker-dealer H.C. Wainwright & Co., LLC (CRD 000000375) · New York, New YorkSold in CA, CT, NY
  • Brookline Capital Markets (CRD 000044656) · broker-dealer Brookline Capital Markets (CRD 000044656) · New York, New YorkSold in CA, CT, NY

Signed by David Gaiero, Chief Financial Officer. Source: SEC Form D, newest notice filed Aug 16, 2024. Read the notice at the SEC.

equity, optionsSEC
Jun 2015$5 MPrivate placement after listing$2 to $10 million

Celsion CORP: Private sale, Jun 2015

Investors in this round

3 investors had bought by the notice of Jun 8, 2015: 3 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $5 M offered
Smallest investment taken
no minimum stated
What was sold
options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Up to $1 million
Sales commissions
none
Finders' fees
$561,750
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jeffrey W. Church · Executive Officer
  • Khursheed H. Anwer · Executive Officer
  • Michael H. Tardugno · Executive Officer, Director
  • Nicholas H. Borys · Executive Officer
  • Alberto W. Martinez · Director
  • Augustine W. Chow · Director
  • Frederick J. Fritz · Director
  • Robert W. Hooper · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Maxim Group LLC (CRD 120708) · New York, New YorkSold in all US states

Remarks in the notice

  • On fees: “Represents the aggregate placement agent fee paid by the issuer relating to the shares of common stock sold in a concurrent registered direct offering and the warrants issued in the private placement reported by this Form D.”

Signed by Jeffrey W. Church, Chief Financial Officer. Source: SEC Form D, newest notice filed Jun 8, 2015. Read the notice at the SEC.

optionsSEC
Jun 2014$9 MPrivate placement after listing$2 to $10 million

Celsion CORP: Private sale, Jun 2014

Investors in this round

1 investor had bought by the notice of Jun 24, 2014: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$9 M of $9 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Up to $1 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jeffrey W. Church · Executive Officer
  • Khursheed H. Anwer · Executive Officer
  • Michael H. Tardugno · Executive Officer, Director
  • Nicholas H. Borys · Executive Officer
  • Alberto E. Martinez · Director
  • Augustine W. Chow · Director
  • Frederick J. Fritz · Director
  • Max E. Link · Director
  • Robert W. Hooper · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “2,712,188 shares of common stock valued at $3.1340 per share were issued as part of the closing consideration to Egen, Inc., an Alabama corporation, for the acquisition by a wholly-owned subsidiary of Celsion of substantially all of Egen?s assets”
  • On a merger: “Shares were issued in connection with the acquisition of substantially all of the assets of Egen, Inc., an Alabama corporation”

Signed by Jeffrey W. Church, Chief Financial Officer. Source: SEC Form D, newest notice filed Jun 24, 2014. Read the notice at the SEC.

equitySEC
Jun 2011$9 MNo. 1$2 to $10 million

Celsion CORP: Raise no. 1, Jun 2011

Investors in this round

31 investors had bought by the notice of Jun 14, 2011: 31 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$9 M of $9 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
$1 million to $5 million
Sales commissions
$527,385
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jeffrey W Church · Executive Officer · Vice President, Chief Financial Officer and Corporate Secretary
  • Michael H. Tardugno · Executive Officer, Director · President, Chief Financial Officer and Director
  • Nicholas W Borys · Executive Officer · Vice President and Chief Medical Officer
  • Robert A Reed · Executive Officer · Vice President, CMC and Technological Operations
  • Timothy J. Tumminello · Executive Officer · Controller and Chief Accounting Officer
  • Alberto R Martinez · Director
  • Augustine R Chow · Director
  • Gregory R Weaver · Director
  • Max E. Link · Director · Chairman of the Board of Directors
  • Robert W Hooper · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Rodman & Renshaw, LLC · New York, New YorkSold in all US states

Remarks in the notice

  • On fees: “Cash Compensation: $527,385.84. Equity Compensation: Warrants to purchase up to 28,384 shares of common stock at an exercise price of $2.77 per share.”

Signed by Jeffrey W. Church, Vp & cfo. Source: SEC Form D, newest notice filed Jun 14, 2011. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Celsion CORP chose not to state its revenue in its newest notice of a funding round (May 2025).

    SEC Form D · May 2025

  • Revenue range over time, as stated in its notices: revenue between $1 million and $5 million in 2011; revenue of up to $1 million in 2014; revenue of up to $1 million in 2015.

    SEC Form D (revenue range) · Jun 2015

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · May 2025

Products and services#

No products or services of Celsion CORP are on record.

Investors#

No investor of Celsion CORP is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 31 investors.

Largest shareholders today

Institutions holding Imunon, Inc. shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Celsion CORP
NameRoleNamed in
David H. GaieroChief Financial OfficerMay 2025
Douglas H. FallerChief Medical OfficerMay 2025
Khursheed H. AnwerExecutive Vice President and Chief Scientific OfficerMay 2025
Michael H. TardugnoExecutive ChairmanMay 2025
Stacy R. LindborgPresident and Chief Executive OfficerMay 2025
Susan H. EylwardGeneral Counsel and Corporate SecretaryMay 2025
David GaieroExecutive officerAug 2024
Khursheed AnwerExecutive officerAug 2024
Michael TardugnoExecutive officerAug 2024
Stacy LindborgExecutive officerAug 2024
Jeffrey W. ChurchExecutive officerJun 2015
Nicholas H. BorysExecutive officerJun 2015
Jeffrey W ChurchVice President, Chief Financial Officer and Corporate SecretaryJun 2011
Nicholas W BorysVice President and Chief Medical OfficerJun 2011
Robert A ReedVice President, CMC and Technological OperationsJun 2011
Timothy J. TumminelloController and Chief Accounting OfficerJun 2011
Christine J. PellizzariDirectorMay 2025
Donald P. BraunDirectorMay 2025
Frederick J. FritzDirectorMay 2025
James E. DentzerDirectorMay 2025
Michael H. TardugnoExecutive ChairmanMay 2025
Stacy R. LindborgPresident and Chief Executive OfficerMay 2025
Christine PellizzariDirectorAug 2024
Donald BraunDirectorAug 2024
Frederick FritzDirectorAug 2024
James DentzerDirectorAug 2024
Stacy LindborgDirectorAug 2024
Alberto W. MartinezDirectorJun 2015
Augustine W. ChowDirectorJun 2015
Robert W. HooperDirectorJun 2015
Alberto E. MartinezDirectorJun 2014
Max E. LinkDirectorJun 2014
Alberto R MartinezDirectorJun 2011
Augustine R ChowDirectorJun 2011
Gregory R WeaverDirectorJun 2011
Robert W HooperDirectorJun 2011

Went public since 2012. Its SEC number is that of a company listed on a stock exchange.